BeStock  
股票 › 生物科技 › ETRA

伊莱克特拉治疗 ETRA

美股市值排名 #3678生物科技
$7.80 +$0.45 (+6.12%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.80 0.00%
开盘$7.72
昨收$7.35
当日区间$7.20 – $8.10
成交量401.3K
市值$476.58M
市盈率(TTM)–
股息率–

基本面

最新报告季度:ANNUAL, ended Dec 2025

营收$0.00
营业利润-$61.89M-135.2% YoY
净利润-$61.98M-150.0% YoY
摊薄每股收益-$1.80-186.4% YoY

盈利能力与资产负债表

资产收益率-89.4%
流动比率7.37
负债/资产比率125.1%
现金及投资$97.73M
总负债$1.16M
净现金(净负债)$96.57M

资产负债表

项目 2026 Q2 2025 Q4 2025 ANNUAL 2024 ANNUAL
-一年内到期融资租赁负债 $827,000.00 $605,000.00 $605,000.00 $0.00
非流动负债合计 $119.64M $119.97M $119.97M $118.49M
-现金及现金等价物 $66.51M $33.01M $33.01M $14.79M
-长期融资租赁负债 $1.16M $1.48M $1.48M $0.00
留存收益 -$221.89M -$172.98M -$172.98M -$111.00M
可转换优先证券 $118.49M $118.49M $118.49M $118.49M
股东权益合计 -$26.77M -$30.33M -$30.33M -$103.26M
股东权益 -$26.77M -$30.33M -$30.33M -$103.26M
股本 $192.69M $133.12M $133.12M $0.00
-普通股 $0.00 $0.00 $0.00 $0.00
-优先股 $192.69M $133.12M $133.12M $0.00
资本公积 $2.45M $9.52M $9.52M $7.74M
不影响留存收益的损益 -$13,000.00 $21,000.00 $21,000.00 $1,000.00
总资产 $106.50M $99.37M $99.37M $19.42M
流动资产合计 $100.36M $95.49M $95.49M $19.42M
现金及现金等价物与短期投资 $97.73M $86.52M $86.52M $15.79M
非流动资产合计 $6.14M $3.88M $3.88M $0.00
短期债务及融资租赁负债 $827,000.00 $605,000.00 $605,000.00 –
负债合计 $133.27M $129.69M $129.69M $122.68M
一年内应计费用 $6.79M $3.03M $3.03M $1.40M
-其他应收款 $264,000.00 $220,000.00 $220,000.00 $55,000.00
预付资产 $1.98M $8.57M $8.57M $3.42M
其他流动资产 $392,000.00 $179,000.00 $179,000.00 $165,000.00
流动负债合计 $13.63M $9.73M $9.73M $4.20M
应收款 $264,000.00 $220,000.00 $220,000.00 $55,000.00
固定资产净值 $2.41M $2.78M $2.78M $0.00
-应付账款 $4.61M $4.08M $4.08M $1.54M
应付款 $4.61M $4.08M $4.08M $1.54M
-短期投资 $31.22M $53.51M $53.51M $998,000.00
其他非流动资产 $3.73M $1.10M $1.10M –
长期债务及融资租赁负债 $1.16M $1.48M $1.48M $0.00
-固定资产原值 $2.41M $2.78M $2.78M $0.00

现金流量表

项目 2025 ANNUAL 2024 ANNUAL
经营活动现金流 -$60.48M -$26.00M
优先股发行净额 $91.68M $0.00
期末现金余额 $33.01M $14.79M
现金净变动 $18.22M $3.70M
期初现金余额 $14.79M $11.09M
自由现金流 -$61.22M -$26.00M
持续经营筹资活动现金流净额 $131.68M $0.00
筹资活动现金流 $131.68M $0.00
投资购置及出售净额 -$52.25M $29.70M
持续经营经营活动现金流净额 -$60.48M -$26.00M
持续经营净利润 -$61.98M -$24.79M
折旧、折耗与摊销 $61,000.00 $0.00
其他非现金项目 $1.65M –
营运资金变动 -$1.74M -$2.80M
-应收款变动 -$165,000.00 $38,000.00
-预付资产变动 -$5.17M -$3.26M
-应付账款及应计费用变动 $4.93M $417,000.00
-其他流动资产变动 -$1.10M $0.00
-其他流动负债变动 -$239,000.00 $0.00
投资活动现金流净额 -$52.98M $29.70M
持续经营投资活动现金流净额 -$52.98M $29.70M
固定资产购置及出售净额 -$733,000.00 $0.00
债务发行及偿还净额 $40.00M $0.00

利润表

项目 2025 ANNUAL 2024 ANNUAL
摊薄每股收益 -$1.80 -$0.63
销售及管理费用 $11.50M $7.05M
营业费用 $61.89M $26.32M
营业总收入 $0.00 $0.00
税前利润 -$61.98M -$24.79M
其他非经营性收入(支出) -$15,000.00 $7,000.00
-管理费用 $11.50M $7.05M
研发费用 $50.39M $19.27M
基本每股收益 -$1.80 -$0.63
归属普通股股东净利润 -$61.98M -$24.79M
归属母公司净利润 -$61.98M -$24.79M
持续经营利润 -$61.98M -$24.79M
净利润 -$61.98M -$24.79M
其他收入(支出) -$15,000.00 $7,000.00
非经营性利息支出 $1.43M $0.00
非经营性利息收入 $1.36M $1.52M
非经营性利息净收入(支出) -$71,000.00 $1.52M
营业利润 -$61.89M -$26.32M

讨论区

暂无评论——快来第一个聊聊 ETRA。

发表评论

Scroll to Top